Stock & Company Details
Innoviva Inc $INVA
Price:
N/A
N/A
72M
$1.5B
52 Week High:
N/A
10 Day Average Volume:
N/A
3.52
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
INVA technical indicators
Latest Innoviva Inc (INVA) indicator readings as of 2026-10-08.
INVA's 14-day RSI is 49.0, in neutral territory. ADX reads 8.5, indicating a range-bound market rather than a trend. MACD (12, 26, 9) is -0.06, below the zero line.
Overview
Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline.
Finance Bot
Ask your questions
Start by typing a question below.